Side-by-side financials for CALC and ABBV. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CALC | ABBV |
|---|---|---|
| Market cap | - | $402.35 B |
| US-listed rank | - | #31 |
| Revenue (latest FY) | - | $61.16B |
| Net income (latest FY) | -$29.56M | $4.23B |
| Net margin | - | 6.9% |
| P/E (trailing FY) | - | 95.2 |
| SEC filings | 474 | 1,008 |
Full pages: CalciMedica, Inc. and AbbVie Inc., or browse the full rankings.